Internal Medicine, Hematology & Oncology · Manhattan, KS
NPI
1942305677
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8301 Positano Dr
Manhattan, KS, 66502
Phone (785) 320-5725
Groups this clinician bills Medicare through
Medicare paid, 2024
$10.0M
640,122 services
Medicare patients, 2024
807
Average age 76
Drug cost, 2024
$5.0M
3,492 prescriptions
Company payments, 2025
$3,756
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Travis Koeneke was code J0185 (injection, aprepitant, 1 mg), 61,880 times for 88 patients. In total Travis Koeneke billed 640,122 services in 130 codes, and Medicare paid $10.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0185 Injection, aprepitant, 1 mg | Office | 61,880 | 88 | $1.34 | $83K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 45,400 | 85 | $4.38 | $199K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 42,000 | 29 | $44.76 | $1.9M |
| J9299 Injection, nivolumab, 1 mg | Office | 34,040 | 14 | $24.53 | $835K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 30,700 | 19 | $0.06 | $1,704 |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 24,750 | 18 | $0.87 | $22K |
| J9264 Injection, paclitaxel protein-bound particles, 1 mg | Office | 24,000 | 12 | $10.63 | $255K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 22,860 | 12 | $39.24 | $897K |
| J9267 Injection, paclitaxel, 1 mg | Office | 21,213 | 21 | $0.08 | $1,675 |
| J0897 Injection, denosumab, 1 mg | Office | 20,760 | 36 | $20.63 | $428K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 12,804 | 27 | $20.72 | $265K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 11,580 | 148 | $0.09 | $1,038 |
| J9312 Injection, rituximab, 10 mg | Office | 8,780 | 25 | $61.26 | $538K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 8,328 | 56 | $0.07 | $611 |
| Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | Office | 5,820 | 14 | $52.03 | $303K |
By year: 2022 $6.6M for 381,868 services; 2023 $8.4M for 545,391 services; 2024 $10.0M for 640,122 services.
Medicare prescription drug claims, 2024
In 2024, the drug Travis Koeneke prescribed most often to Medicare patients was Anastrozole, with 638 prescriptions and refills. In total Travis Koeneke wrote 3,492 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 638 | 1,113 | 123 | $7,331 |
| Prednisone Generic | 215 | 244 | 73 | $1,022 |
| Tamoxifen Citrate Generic | 191 | 308 | 34 | $3,310 |
| Acyclovir Generic | 177 | 201 | 34 | $1,784 |
| Gabapentin Generic | 132 | 155 | 29 | $1,085 |
| Prochlorperazine Maleate Generic | 116 | 116 | 63 | $1,574 |
| Potassium Chloride Generic | 97 | 120 | 42 | $679 |
| Eliquis Apixaban | 95 | 115 | 18 | $68K |
| Hydroxyurea Generic | 89 | 127 | 18 | $2,065 |
| Dexamethasone Generic | 84 | 91 | 44 | $1,777 |
| Ondansetron Hcl Generic | 80 | 80 | 41 | $1,895 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 73 | 73 | 31 | $1,606 |
| Letrozole Generic | 69 | 113 | 13 | $751 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 66 | 66 | 18 | $1,110 |
| Omeprazole Generic | 61 | 89 | 11 | $237 |
Brand drugs: 500 claims; generic drugs: 2,992 claims; opioid claims: 159.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Travis Koeneke $3,756 ($3,756 in general payments such as food, travel and fees) from 42 companies. The largest payer was Geron Corporation with $800.
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation GERN | 3 | $800 |
| Janssen Biotech, Inc. JNJ | 13 | $288 |
| Pfizer Inc. PFE | 18 | $260 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $249 |
| Merck Sharp & Dohme LLC MRK | 7 | $140 |
| GlaxoSmithKline, LLC. GSK | 6 | $125 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $122 |
| Genentech USA, Inc. ROG.SW | 6 | $122 |
| Astellas Pharma US Inc 4503.T | 5 | $115 |
| Abbvie Inc. ABBV | 5 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.